Bal Pharma Limited

BALPHARMA

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 202688

    Quarter₹ croreYoY
    Jun 202473+4.2%
    Sept 202475-19.1%
    Dec 202473-10.6%
    Mar 202582-13.5%
    Jun 202566-10.2%
    Sept 202574-1.3%
    Dec 202587+20.0%
    Mar 202684+2.6%
    Jun 202688+34.7%
  • ₹ crore

    Jun 20260.46

    Quarter₹ crore
    Jun 20240.81
    Sept 20240.36
    Dec 20240.82
    Mar 20250.99
    Jun 20250.74
    Sept 20251
    Dec 20250.35
    Mar 2026-0.22
    Jun 20260.46
  • ₹ crore

    Jun 202689

    Quarter₹ crore
    Jun 202474
    Sept 202475
    Dec 202474
    Mar 202583
    Jun 202566
    Sept 202575
    Dec 202588
    Mar 202684
    Jun 202689
  • Cost structure
  • ₹ crore

    Jun 202617

    Quarter₹ crore
    Jun 202414
    Sept 202415
    Dec 202415
    Mar 202515
    Jun 202515
    Sept 202516
    Dec 202517
    Mar 202618
    Jun 202617
  • ₹ crore

    Jun 202688

    Quarter₹ crore
    Jun 202472
    Sept 202474
    Dec 202473
    Mar 202580
    Jun 202566
    Sept 202574
    Dec 202586
    Mar 202680
    Jun 202688
  • Exceptional items and tax
  • ₹ crore

    Jun 20261

    Quarter₹ crore
    Jun 20242
    Sept 20242
    Dec 20241
    Mar 20253
    Jun 20250.32
    Sept 20250.78
    Dec 20252
    Mar 20263
    Jun 20261
  • ₹ crore

    Jun 20260

    Quarter₹ crore
    Jun 20240.36
    Sept 20240.32
    Dec 20240.05
    Mar 2025-3
    Jun 20250
    Sept 20250
    Dec 20250
    Mar 2026-0.39
    Jun 20260
  • Profit
  • ₹ crore

    Jun 20261

    Quarter₹ croreYoY
    Jun 20242+46.3%
    Sept 20241-24.2%
    Dec 20241-8.1%
    Mar 20256-9.8%
    Jun 20250.32-81.5%
    Sept 20250.78-35.6%
    Dec 20252+68.4%
    Mar 20264-34.0%
    Jun 20261+259.1%
  • Per share
  • ₹ per share

    Jun 20260.73

    Quarter₹ per share
    Jun 20241.11
    Sept 20240.76
    Dec 20240.73
    Mar 20253.51
    Jun 20250.20
    Sept 20250.49
    Dec 20251.22
    Mar 20262.60
    Jun 20260.73
₹ croreJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
737573826674878488
Revenue YoY+4.2%-19.1%-10.6%-13.5%-10.2%-1.3%+20.0%+2.6%+34.7%
0.810.360.820.990.7410.35-0.220.46
747574836675888489
Cost structure
141515151516171817
727473806674868088
Exceptional items and tax
22130.320.78231
0.360.320.05-3000-0.390
Profit
21160.320.78241
Net profit YoY+46.3%-24.2%-8.1%-9.8%-81.5%-35.6%+68.4%-34.0%+259.1%
Per share
1.110.760.733.510.200.491.222.600.73

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.